Latest News About Moderna Stock

Here are the latest general signals on Moderna stock (MRNA) as of May 2026:

• Shares have shown volatility around updated 2025-2026 guidance, with investors reacting to quarterly results and pipeline milestones. Recent articles note market moves on upbeat 2025 sales and 2026 outlook, though specifics vary by source.[1][6][10]
• The broader coverage includes updates on revenue progression, cash position, and pipeline development beyond COVID-19, with attention to potential catalysts in Europe and other markets. Analysts and financial outlets often highlight Moderna’s goal of cash-flow break-even by 2028 and ongoing mRNA programs as long-term value drivers.[2][9][1]
• For real-time quotes and intraday moves, financial platforms like Google Finance, Yahoo Finance, Investing.com, and CNBC provide updated price feeds and headlines. Use those sources if you need current tick-by-tick data and day-to-day performance.[3][4][5][1]

Would you like me to pull the most current price, intraday change, and key headlines from a specific source (e.g., Yahoo Finance or MarketWatch) and summarize them with a price chart? I can also create a quick table comparing recent catalysts and their potential impacts on MRNA. If you have a preferred market (U.S. or European listings) or a specific date range, tell me and I’ll tailor the snapshot.